1 active not recruiting, 1 terminated. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Terminated 1 |
Follow Hyper-Igm Immunodeficiency Syndrome: new trials by email Literature Review of Hyper-Igm Immunodeficiency Syndrome trials Research Report on Hyper-Igm Immunodeficiency Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome | Not applicable | Active not recruiting | Masonic Cancer Center, University of Minnesota | 57 | 2012-09-04 | 2026-06-17 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies anti-thymocyte globulin, busulfan, cyclophosphamide - Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome | Not applicable | Terminated | Fairview University Medical Center | 2000-03-01 | 2009-10-15 |
Chediak-Higashi Syndrome (2) · Common Variable Immunodeficiency (2) · Granulomatous Disease, Chronic (2) · Histiocytosis, Langerhans-Cell (2) · Immunologic Deficiency Syndromes (2) · Lymphohistiocytosis, Hemophagocytic (2) · Lymphoproliferative Disorders (2) · Severe Combined Immunodeficiency (2) · Wiskott-Aldrich Syndrome (2) · Bruton type agammaglobulinemia (1) · Communicable Diseases (1) · Genetic Diseases, Inborn (1) · Graft vs Host Disease (1) · Hematologic Diseases (1) · Hereditary Complement Deficiency Diseases (1)
Albinism (2) · Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Blood Protein Disorders (2) · Chronic Disease (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cytopenia (2) · DNA Repair-Deficiency Disorders (2) · Disease Attributes (2) · Dysgammaglobulinemia (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, X-Linked (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2)
Busulfan (2) · Cyclophosphamide (2) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Cyclosporine (1) · Etoposide (1) · Melphalan (1) · Mesna (1) · Methotrexate (1) · Methylprednisolone (1) · Prednisone (1) · Sodium (1) · Stem Cell Transplantation (1) · fludarabine phosphate (1)
Fairview University Medical Center (1) · Masonic Cancer Center, University of Minnesota (1)
United States (2)
K. Scott Baker (1) · Meera Srikanthan, MD (1)